Monro Inc. (MNRO)
Valuation Overview•Is Monro Inc. Overvalued or Undervalued?
Commands a premium valuation multiple over its peers, likely pricing in superior execution.
Fragile underlying quality score of 32/100; weak margins or elevated debt leverage warrant caution.
Analysts remain bullish, forecasting further upside expansion with consensus targets suggesting solid gains.
Confirm your valuation thesis with live pattern overlays, key pivot levels, and AI trade plans.
Verdict: Mixed fundamental profile with offsetting strengths and weaknesses.
Wall Street is highly bullish, projecting significant upside alongside robust expected earnings growth. This outlook is strongly supported by highly attractive capital returns, anchored by a strong, well-covered dividend yield.
MNRO struggles with subpar profitability and pressured margins. However, this is severely offset by a highly leveraged balance sheet (Debt/EBITDA > 4.0x) and elevated financial risk.
The company is facing top-line contraction (-4.4% 3Y CAGR) however, earnings have severely contracted over the same period. However, profitability remains a major concern with severely compressed operating margins (3.3%).
| Financial Metric | Trend (12Q) | Latest Qtr | 1Y Growth | 3Y CAGR | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| Revenue | $287.1M | -3.2% | -4.4% | +0.6% | +2.1% | |
| EBITDA | $19.3M | — | -21.1% | — | — | |
| Net Income | -$2.1M | +141.9% | -61.8% | — | -29.0% | |
| EPS (Diluted) | $-0.08 | +112.5% | -71.4% | -51.3% | -34.9% | |
| Free Cash Flow | -$37.9M | -63.3% | -39.6% | -21.9% | — |
| Metric | TTM | 3Y Avg | 5Y Avg | 10Y Avg |
|---|---|---|---|---|
| Gross Margin | 34.9% | 35.1% | 35.0% | 36.5% |
| Operating Margin | 3.3% | 3.4% | 4.8% | 7.3% |
| Net Margin | 0.7% | 0.9% | 2.0% | 3.6% |
| FCF Margin | 3.7% | 6.7% | 8.8% | 8.7% |
| Quarter | EPS Est. | EPS Act. | Surprise | EPS | Rev |
|---|---|---|---|---|---|
| Q3'26Latest | $0.04 | $-0.09 | -325.0% | ||
| Q2'26 | $-0.04 | $-0.16 | -300.0% | ||
| Q1'26 | $0.12 | $0.16 | +33.3% | ||
| Q4'25 | $0.18 | $0.21 | +16.7% | ||
| Q3'25 | $0.17 | $0.22 | +29.4% | ||
| Q2'25 | $0.09 | $-0.09 | -200.0% | ||
| Q1'25 | $0.31 | $0.19 | -38.7% | ||
| Q4'24 | $0.26 | $0.17 | -34.6% |
Total return is -16.6% (1Y), lagging the benchmark by -32.4%
| Period | Total Return | vs S&P 500 (Alpha) | Dividend Contribution |
|---|---|---|---|
| YTD | -24.6% | -37.0% | — |
| 1Y | -16.6% | -32.4% | +6.2% |
| 3YCAGR | -14.8% | -35.8% | +11.9% |
| 5YCAGR | -20.4% | -31.2% | +9.1% |
| 10YCAGR | -9.1% | -22.5% | — |
The S&P 500 is at 31.3x trailing P/E — Expensive relative to historical averages.
Quick answers to common questions about Monro Inc. (MNRO) valuation, health, and returns.
Based on peer relative multiples, Monro Inc. appears Expensive versus peers compared to industry peers.
Monro Inc. has multiple valuation anchors: Peer Relative Fair Value: $8.81 | Wall Street Analyst Target: $16.50 (implying +17.7% upside). A convergence of these signals offers higher conviction.
Monro Inc. displays weak financial health with a composite quality score of 32/100, supported by a Altman Z-Score of 1.0 (distress zone), Piotroski F-Score of 7/9, Return on Invested Capital (ROIC) of 1.1%.
Monro Inc. pays a 8.3% dividend yield, covered by a 1609% payout ratio with 0 years of growth, supplemented by a 0.0% buyback yield.
Monro Inc.'s current growth trajectory is Stable. The company achieved -3.2% 1Y revenue growth and +112.5% 1Y EPS growth, compared to its 3Y revenue CAGR of -4.4%.
Wall Street consensus is Hold based on 24 analysts, beating EPS expectations in 42% of recent quarters with a -2-quarter streak. The consensus price target represents a +17.7% change from current levels.
Investment risks for Monro Inc. include: -52.7% 1-year max drawdown, high beta (1.80x market volatility), elevated distress risk, stretched payout ratio. Volatility risk is characterized by a beta of 1.80x.
No. These computations are purely quantitative model outputs for informational purposes. They do not account for qualitative management shifts or macro events. Always consult a licensed RIA before buying or selling shares.
Disclaimer: This page is for informational purposes only and does not constitute financial advice. All valuation models, scores, and target estimates are automated computations under stated assumptions and should not be relied upon as the sole basis for any investment decision.